Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non Operating Income (2022 - 2026)

Cannabis Bioscience International Holdings' Non Operating Income history spans 5 years, with the latest figure at -$10675.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 79.47% to -$10675.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$116470.0, a 25.77% increase, with the full-year FY2025 number at -$127455.0, up 22.85% from a year prior.
  • Non Operating Income hit -$10675.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$21090.0 in the prior quarter.
  • Over the last five years, Non Operating Income for CBIH hit a ceiling of $21299.0 in Q3 2024 and a floor of -$106302.0 in Q2 2024.
  • Historically, Non Operating Income has averaged -$31049.9 across 5 years, with a median of -$25503.0 in 2023.
  • The widest YoY moves for Non Operating Income: up 525.55% in 2024, down 9502.71% in 2024.
  • Tracing CBIH's Non Operating Income over 5 years: stood at -$36278.0 in 2022, then increased by 17.54% to -$29916.0 in 2023, then skyrocketed by 33.48% to -$19901.0 in 2024, then dropped by 5.97% to -$21090.0 in 2025, then skyrocketed by 49.38% to -$10675.0 in 2026.
  • Business Quant data shows Non Operating Income for CBIH at -$10675.0 in Q1 2026, -$21090.0 in Q4 2025, and -$7861.0 in Q3 2025.